\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ polyp\\ was\\ biopsied\\ and\\ sent\\ for\\ pathologic\\ diagnosis\\.\ \(0\)\
\-\ treatment\\ for\\ colorectal\\ carcinoma\\ depends\\ on\\ the\\ staging\\ of\\ the\\ disease\\.\\ \\ treatment\\ options\\ include\\ partial\\ or\\ total\\ colectomy\\,\\ radiation\\ therapy\\,\\ and\\ chemotherapy\\.\\ \\ radiation\\ therapy\\ may\\ be\\ used\\ before\\ surgery\\ to\\ shrink\\ the\\ tumor\\ or\\ after\\ surgery\\ as\\ an\\ adjuvant\\ therapy\\.\\ \\ if\\ the\\ cancerous\\ polyp\\ is\\ small\\,\\ generally\\ laparoscopic\\ surgery\\ is\\ utilized\\ due\\ to\\ the\\ decreased\\ amount\\ of\\ side\\-effects\\ and\\ healing\\ time\\ as\\ compared\\ to\\ open\\ surgery\\.\\ once\\ the\\ cancer\\ is\\ staged\\,\\ the\\ decision\\ to\\ use\\ chemotherapy\\ is\\ determined\\ by\\ presence\\ of\\ local\\ or\\ distal\\ metastasis\\.\\ \\(4\\)\ \(0\)\
\-\ virtual\\ colonoscopy\\ can\\ create\\ a\\ three\\ dimensional\\ \\(3d\\)\\ anatomic\\ model\\ of\\ the\\ colon\\ using\\ data\\ from\\ volumetrically\\ acquired\\ computed\\ tomography\\ \\(ct\\)\\ scan\\ \\(fig\\ 1a\\)\\.\\ \\ an\\ axial\\ slice\\ from\\ the\\ ct\\ scan\\ shows\\ a\\ 9\\ mm\\ pedunculated\\ polyp\\ in\\ the\\ sigmoid\\ colon\\,\\ approximately\\ 60\\ cm\\ from\\ the\\ anus\\ \\(fig\\.\\ 2a\\)\\.\\ \\ a\\ 3d\\ endoluminal\\ view\\ of\\ the\\ colon\\ shows\\ a\\ better\\ depiction\\ of\\ the\\ polyp\\ \\(fig\\.\\ 1b\\,\\ 2a\\,\\ 3\\,\\ 4a\\)\\.\ \(0\)\
\-\ examples\\ of\\ fly\\ through\\ vc\\ model\\ below\\ \\(not\\ actual\\ patient\\)\\:\ \(0\)\
\-\ a\\ flat\\ hyperplastic\\ polyp\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc1\\.avi\ \(0\)\
\-\ sessile\\ polyp\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc2\\.avi\ \(0\)\
\-\ tva\\ severe\\ dysplasia\\ polyp\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/multimedia\\_files\\/vc3\\.avi\ \(0\)\
\-\ \\ \\ \\ \\ \\ the\\ patient\\ was\\ recommended\\ to\\ undergo\\ optical\\ colonoscopy\\ \\(oc\\)\\ to\\ confirm\\ the\\ presence\\ of\\ the\\ polyp\\.\\ the\\ oc\\ confirmed\\ the\\ presence\\ of\\ a\\ 1\\.5\\ cm\\ pedunculated\\ polyp\\,\\ located\\ 50\\ cm\\ from\\ the\\ anus\\ \\(fig\\.\\ 4b\\)\\.\ \(0\)\
\-\ invasive\\ colonic\\ adenocarcinoma\\:\ \(0\)\
\-\ biopsy\\ of\\ the\\ polyp\\ showed\\ micro\\-invasive\\ colonic\\ adenocarcinoma\\,\\ without\\ invasion\\ of\\ the\\ lymphatic\\,\\ vascular\\,\\ or\\ perineural\\ space\\.\ \(0\)\
\-\ \\â\\€\\¢\\ invasive\\ colonic\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ intramucosal\\ colonic\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ adenoma\\ \\(tubular\\,\\ villous\\,\\ and\\ tubulovillous\\)\ \(0\)\
\-\ \\â\\€\\¢\\ hyperplastic\\ polyp\\ \ \(0\)\
\-\ \\â\\€\\¢\\ fibroblastic\\ polyp\ \(0\)\
\-\ \\â\\€\\¢\\ inflammatory\\ polyp\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoid\\ polyp\ \(0\)\
\-\ a\\ 51\\-year\\-old\\ male\\ with\\ no\\ known\\ symptoms\\ undergoes\\ with\\ routine\\ screening\\ for\\ colorectal\\ carcinoma\\ with\\ virtual\\ colonoscopy\\.\ \(0\)\
\-\ colon\\ cancer\\ is\\ the\\ third\\ most\\ diagnosed\\ \\(1\\)\\ malignant\\ neoplasm\\ and\\ second\\ leading\\ cause\\ of\\ cancer\\ related\\ mortality\\ in\\ the\\ united\\ states\\.\\ \\(2\\)\\ \\ despite\\ being\\ so\\ deadly\\,\\ colorectal\\ carcinoma\\ is\\ also\\ one\\ of\\ the\\ most\\ preventable\\ types\\ of\\ cancer\\.\\ \\ it\\ is\\ generally\\ recommended\\ that\\ all\\ men\\ and\\ women\\ over\\ the\\ age\\ of\\ 50\\ get\\ colon\\ cancer\\ screening\\ every\\ 5\\ to\\ 10\\ years\\.\\ \\(5\\)\\ \\ however\\,\\ it\\ is\\ noted\\ that\\ only\\ approximately\\ 30\\%\\ of\\ people\\ eligible\\ to\\ get\\ screened\\ actually\\ get\\ screened\\.\\ \\(6\\)\\ this\\ statistic\\ is\\ important\\ because\\ the\\ latency\\ period\\ for\\ colorectal\\ carcinoma\\ is\\ 10\\ to\\ 20\\ years\\.\\ \\ the\\ traditional\\ gold\\ standard\\ for\\ colorectal\\ screening\\ has\\ been\\ oc\\,\\ which\\ is\\ invasive\\,\\ requires\\ sedation\\,\\ and\\ a\\ full\\ bowel\\ cleanse\\ the\\ day\\ before\\.\\ this\\ may\\ be\\ too\\ overwhelming\\ for\\ asymptomatic\\ individuals\\ that\\ should\\ be\\ screened\\.\\ \\ one\\ hope\\ is\\ that\\ vc\\ will\\ help\\ make\\ the\\ screening\\ process\\ more\\ convenient\\ without\\ jeopardizing\\ the\\ sensitivity\\ and\\ specificity\\ of\\ the\\ test\\.\ \(0\)\
\-\ computed\\ tomography\\ \\(ct\\)\\ colonography\\ or\\ vc\\ is\\ a\\ technique\\ that\\ utilizes\\ volumetrically\\ acquired\\ helical\\ ct\\ scan\\ of\\ the\\ abdomen\\ to\\ produce\\ two\\-dimensional\\ and\\ three\\ dimensional\\ images\\ of\\ the\\ colon\\.\\ \\(6\\)\\ \\ these\\ images\\ can\\ detect\\ colon\\ polyps\\ of\\ varying\\ sizes\\.\\ \\ to\\ get\\ the\\ best\\ image\\ of\\ the\\ colon\\,\\ carbon\\ dioxide\\ is\\ used\\ to\\ inflate\\ the\\ colon\\ through\\ a\\ flexible\\ rectal\\ tube\\ \\(about\\ the\\ size\\ of\\ a\\ pencil\\)\\.\ \(0\)\
\-\ differential\\ considerations\\ for\\ a\\ polyp\\ in\\ the\\ colon\\ include\\:\\ hyperplastic\\ polyp\\,\\ fibroblastic\\ polyp\\,\\ inflammatory\\ polyp\\,\\ lymphoid\\ polyp\\,\\ adenoma\\ \\(tubular\\,\\ villous\\,\\ and\\ tubulovillous\\)\\,\\ intramucosal\\ colonic\\ adenocarcinoma\\,\\ and\\ invasive\\ colonic\\ adenocarcinoma\\.\\ \\ a\\ hyperplastic\\ polyp\\ is\\ a\\ benign\\ growth\\ of\\ the\\ colonic\\ endothelium\\.\\ \\ adenomas\\ are\\ neoplastic\\ benign\\ growths\\ of\\ the\\ colonic\\ epithelium\\ that\\ are\\ direct\\ precursors\\ to\\ adenocarcinoma\\.\\ \\ tubular\\ adenomas\\ arise\\ from\\ tubular\\ glands\\ of\\ the\\ colon\\ wall\\ and\\ account\\ for\\ a\\ majority\\ of\\ adenomas\\ found\\ in\\ the\\ colon\\.\\ \\ villous\\ adenomas\\ develop\\ from\\ the\\ villous\\ projections\\ and\\ only\\ make\\ up\\ 1\\%\\ of\\ adenomas\\ found\\ within\\ the\\ colon\\.\\ \\ tubulovillous\\ adenomas\\ are\\ a\\ combination\\ of\\ tubular\\ and\\ villous\\ adenomas\\ and\\ account\\ for\\ 5\\%\\ to\\ 10\\%\\ of\\ adenomas\\ discovered\\.\\ \\ intramucosal\\ carcinomas\\ are\\ malignant\\ cells\\ confined\\ to\\ the\\ bowel\\ mucosa\\.\\ \\ invasive\\ carcinomas\\ occur\\ when\\ these\\ malignant\\ cells\\ extend\\ into\\ the\\ submucosa\\ of\\ the\\ colon\\ wall\\.\\ \\(3\\)\\ \\ \ \(0\)\
\-\ in\\ conclusion\\,\\ vc\\ is\\ a\\ minimally\\ invasive\\ alternative\\ for\\ colorectal\\ screening\\ that\\ has\\ the\\ potential\\ to\\ greatly\\ increase\\ compliance\\.\\ \\ there\\ is\\ a\\ national\\ study\\ in\\ progress\\ being\\ conducted\\ by\\ the\\ american\\ college\\ of\\ radiology\\ imaging\\ network\\ \\(acrin\\)\\ \\(12\\)\\ to\\ confirm\\ the\\ positive\\ findings\\ from\\ the\\ earlier\\ department\\ of\\ defense\\ \\(dod\\)\\ study\\.\\ the\\ authors\\ believe\\ that\\ vc\\ will\\ have\\ a\\ large\\ positive\\ impact\\ on\\ public\\ health\\ because\\ early\\ detection\\ of\\ colon\\ cancer\\ should\\ substantially\\ reduce\\ the\\ mortality\\ from\\ colon\\ cancer\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polyp\\:\\ 0\\.4636278733440739\ \(0\)\
\-\ colon\\:\\ 0\\.2773559021386502\ \(0\)\
\-\ the\\:\\ 0\\.2453074505592963\ \(0\)\
\-\ adenomas\\:\\ 0\\.21192876219956608\ \(0\)\
\-\ vc\\:\\ 0\\.18204250326410254\ \(0\)\
\-\ colonic\\:\\ 0\\.17775121620921466\ \(0\)\
\-\ colorectal\\:\\ 0\\.17020144077089483\ \(0\)\
\-\ villous\\:\\ 0\\.1601193790679362\ \(0\)\
\-\ of\\:\\ 0\\.1470246483433136\ \(0\)\
\-\ invasive\\:\\ 0\\.1450145086833954\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.13025465416032805\ \(0\)\
\-\ hyperplastic\\:\\ 0\\.10969386233668428\ \(0\)\
\-\ intramucosal\\:\\ 0\\.10922550195846151\ \(0\)\
\-\ cancer\\:\\ 0\\.10614843142474471\ \(0\)\
\-\ is\\:\\ 0\\.10599067244589218\ \(0\)\
\-\ oc\\:\\ 0\\.10437079824872393\ \(0\)\
\-\ fig\\:\\ 0\\.09994116918189029\ \(0\)\
\-\ get\\:\\ 0\\.0990540392919406\ \(0\)\
\-\ tubular\\:\\ 0\\.09889550033371006\ \(0\)\
\-\ tubulovillous\\:\\ 0\\.09825459490314722\ \(0\)\
\-\ to\\:\\ 0\\.09675662789378497\ \(0\)\
\-\ screening\\:\\ 0\\.09247047351340032\ \(0\)\
\-\ screened\\:\\ 0\\.09121692373102411\ \(0\)\
\-\ dimensional\\:\\ 0\\.08881425886488761\ \(0\)\
\-\ that\\:\\ 0\\.07903826427937236\ \(0\)\
\-\ volumetrically\\:\\ 0\\.072817001305641\ \(0\)\
\-\ from\\:\\ 0\\.07233493172804148\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.07117411501687507\ \(0\)\
\-\ and\\:\\ 0\\.07056610468935073\ \(0\)\
\-\ for\\:\\ 0\\.06900334532258258\ \(0\)\
\-\ fibroblastic\\:\\ 0\\.06281730316646282\ \(0\)\
\-\ 2a\\:\\ 0\\.061751440228358066\ \(0\)\
\-\ model\\:\\ 0\\.06081128248734941\ \(0\)\
\-\ virtual\\:\\ 0\\.05728452262782135\ \(0\)\
\-\ lymphoid\\:\\ 0\\.055734746983792424\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05447143178890303\ \(0\)\
\-\ 3d\\:\\ 0\\.053676725371283596\ \(0\)\
\-\ anus\\:\\ 0\\.053321906288471284\ \(0\)\
\-\ pedunculated\\:\\ 0\\.050939300913564585\ \(0\)\
\-\ carcinomas\\:\\ 0\\.050939300913564585\ \(0\)\
\-\ http\\:\\ 0\\.050493800542085576\ \(0\)\
\-\ presence\\:\\ 0\\.04907371352066436\ \(0\)\
\-\ surgery\\:\\ 0\\.04896081344458675\ \(0\)\
\-\ malignant\\:\\ 0\\.04868619838410466\ \(0\)\
\-\ account\\:\\ 0\\.04636278733440739\ \(0\)\
\-\ mortality\\:\\ 0\\.044787441625654296\ \(0\)\
\-\ make\\:\\ 0\\.04421294087142499\ \(0\)\
\-\ tomography\\:\\ 0\\.04410284098730607\ \(0\)\
\-\ acquired\\:\\ 0\\.043887095014780594\ \(0\)\
\-\ computed\\:\\ 0\\.043887095014780594\ \(0\)\
\-\ confirm\\:\\ 0\\.04261116429400064\ \(0\)\
\-\ scan\\:\\ 0\\.040521235879607494\ \(0\)\
\-\ 10\\:\\ 0\\.039937980977254706\ \(0\)\
\-\ or\\:\\ 0\\.03960020286313242\ \(0\)\
\-\ therapy\\:\\ 0\\.039242396381841065\ \(0\)\
\-\ cm\\:\\ 0\\.039225081595644744\ \(0\)\
\-\ generally\\:\\ 0\\.03857006044866459\ \(0\)\
\-\ before\\:\\ 0\\.036810801770874355\ \(0\)\
\-\ tva\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ statistic\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ cleanse\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ convenient\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ jeopardizing\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ inflate\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ growths\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ acrin\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ defense\\:\\ 0\\.0364085006528205\ \(0\)\
\-\ adenoma\\:\\ 0\\.036301131975658124\ \(0\)\
\-\ recommended\\:\\ 0\\.0362192634113602\ \(0\)\
\-\ cells\\:\\ 0\\.035082447872338246\ \(0\)\
\-\ 4a\\:\\ 0\\.03479026608290798\ \(0\)\
\-\ 4b\\:\\ 0\\.03479026608290798\ \(0\)\
\-\ latency\\:\\ 0\\.03479026608290798\ \(0\)\
\-\ precursors\\:\\ 0\\.03479026608290798\ \(0\)\
\-\ dod\\:\\ 0\\.03479026608290798\ \(0\)\
\-\ ct\\:\\ 0\\.034669596328985995\ \(0\)\
\-\ are\\:\\ 0\\.03455532075090201\ \(0\)\
\-\ used\\:\\ 0\\.03408753753515068\ \(0\)\
\-\ in\\:\\ 0\\.033981314813534697\ \(0\)\
\-\ deadly\\:\\ 0\\.03364211038349977\ \(0\)\
\-\ preventable\\:\\ 0\\.03364211038349977\ \(0\)\
\-\ utilizes\\:\\ 0\\.03364211038349977\ \(0\)\
\-\ pencil\\:\\ 0\\.03364211038349977\ \(0\)\
\-\ optical\\:\\ 0\\.03275153163438241\ \(0\)\
\-\ dioxide\\:\\ 0\\.03275153163438241\ \(0\)\
\-\ endothelium\\:\\ 0\\.03275153163438241\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.03233136320299309\ \(0\)\
\-\ cancerous\\:\\ 0\\.03202387581358724\ \(0\)\
\-\ 1b\\:\\ 0\\.03202387581358724\ \(0\)\
\-\ network\\:\\ 0\\.03202387581358724\ \(0\)\
\-\ because\\:\\ 0\\.03182246733099179\ \(0\)\
\-\ 50\\:\\ 0\\.03179902497920716\ \(0\)\
\-\ being\\:\\ 0\\.03172910819602613\ \(0\)\
\-\ endoluminal\\:\\ 0\\.03140865158323141\ \(0\)\
\-\ depiction\\:\\ 0\\.03140865158323141\ \(0\)\
\-\ fly\\:\\ 0\\.03140865158323141\ \(0\)\
\-\ overwhelming\\:\\ 0\\.03140865158323141\ \(0\)\
\-\ colonography\\:\\ 0\\.03140865158323141\ \(0\)\
\-\ public\\:\\ 0\\.03140865158323141\ \(0\)\
\-\ benign\\:\\ 0\\.03127802123223288\ \(0\)\
\-\ shrink\\:\\ 0\\.030875720114179033\ \(0\)\
\-\ slice\\:\\ 0\\.030875720114179033\ \(0\)\
\-\ eligible\\:\\ 0\\.030875720114179033\ \(0\)\
\-\ flexible\\:\\ 0\\.030875720114179033\ \(0\)\
\-\ submucosa\\:\\ 0\\.030875720114179033\ \(0\)\
\-\ substantially\\:\\ 0\\.030875720114179033\ \(0\)\
\-\ inflammatory\\:\\ 0\\.030788950455017478\ \(0\)\
\-\ three\\:\\ 0\\.030565233224186764\ \(0\)\
\-\ staged\\:\\ 0\\.030405641243674706\ \(0\)\
\-\ perineural\\:\\ 0\\.030405641243674706\ \(0\)\
\-\ hope\\:\\ 0\\.030405641243674706\ \(0\)\
\-\ study\\:\\ 0\\.030367155689401452\ \(0\)\
\-\ radiation\\:\\ 0\\.030173874695343245\ \(0\)\
\-\ positive\\:\\ 0\\.03000383504540052\ \(0\)\
\-\ 1a\\:\\ 0\\.02998514136506167\ \(0\)\
\-\ should\\:\\ 0\\.0297102069024581\ \(0\)\
\-\ undergoes\\:\\ 0\\.029604752954962538\ \(0\)\
\-\ found\\:\\ 0\\.029461854401361096\ \(0\)\
\-\ will\\:\\ 0\\.02930618525224387\ \(0\)\
\-\ compliance\\:\\ 0\\.0292574855442665\ \(0\)\
\-\ bowel\\:\\ 0\\.029220996449578044\ \(0\)\
\-\ approximately\\:\\ 0\\.029053298789023314\ \(0\)\
\-\ sedation\\:\\ 0\\.028938030493667753\ \(0\)\
\-\ traditional\\:\\ 0\\.028642261313910674\ \(0\)\
\-\ helical\\:\\ 0\\.028642261313910674\ \(0\)\
\-\ only\\:\\ 0\\.02844636579591291\ \(0\)\
\-\ examples\\:\\ 0\\.028366906795149138\ \(0\)\
\-\ actual\\:\\ 0\\.028366906795149138\ \(0\)\
\-\ conclusion\\:\\ 0\\.028366906795149138\ \(0\)\
\-\ college\\:\\ 0\\.028366906795149138\ \(0\)\
\-\ believe\\:\\ 0\\.028366906795149138\ \(0\)\
\-\ years\\:\\ 0\\.02791105139198608\ \(0\)\
\-\ create\\:\\ 0\\.027867373491896212\ \(0\)\
\-\ sessile\\:\\ 0\\.027867373491896212\ \(0\)\
\-\ national\\:\\ 0\\.027867373491896212\ \(0\)\
\-\ be\\:\\ 0\\.027706308859098732\ \(0\)\
\-\ wall\\:\\ 0\\.02769818237571645\ \(0\)\
\-\ colectomy\\:\\ 0\\.02742346558417107\ \(0\)\
\-\ carbon\\:\\ 0\\.02742346558417107\ \(0\)\
\-\ greatly\\:\\ 0\\.02742346558417107\ \(0\)\
\-\ through\\:\\ 0\\.02710464373676683\ \(0\)\
\-\ include\\:\\ 0\\.027091654124387708\ \(0\)\
\-\ alternative\\:\\ 0\\.02702402674399814\ \(0\)\
\-\ biopsied\\:\\ 0\\.026838362685641798\ \(0\)\
\-\ shows\\:\\ 0\\.026723866533368657\ \(0\)\
\-\ projections\\:\\ 0\\.026660953144235642\ \(0\)\
\-\ authors\\:\\ 0\\.026660953144235642\ \(0\)\
\-\ depends\\:\\ 0\\.02649109527494576\ \(0\)\
\-\ adjuvant\\:\\ 0\\.02649109527494576\ \(0\)\
\-\ people\\:\\ 0\\.02649109527494576\ \(0\)\
\-\ conducted\\:\\ 0\\.026328172346623567\ \(0\)\
\-\ sizes\\:\\ 0\\.026171640224347016\ \(0\)\
\-\ epithelium\\:\\ 0\\.026171640224347016\ \(0\)\
\-\ one\\:\\ 0\\.026069716112418807\ \(0\)\
\-\ lymphatic\\:\\ 0\\.026021016404441436\ \(0\)\
\-\ specificity\\:\\ 0\\.026021016404441436\ \(0\)\
\-\ decision\\:\\ 0\\.025875871044589934\ \(0\)\
\-\ gold\\:\\ 0\\.025875871044589934\ \(0\)\
\-\ these\\:\\ 0\\.025712414951460486\ \(0\)\
\-\ utilized\\:\\ 0\\.025469650456782292\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.024985292295472573\ \(0\)\
\-\ united\\:\\ 0\\.02487286070503323\ \(0\)\
\-\ actually\\:\\ 0\\.02487286070503323\ \(0\)\
\-\ detect\\:\\ 0\\.024553405654434483\ \(0\)\
\-\ polyps\\:\\ 0\\.024553405654434483\ \(0\)\
\-\ confined\\:\\ 0\\.024353811189185965\ \(0\)\
\-\ glands\\:\\ 0\\.02416372490597528\ \(0\)\
\-\ impact\\:\\ 0\\.02407197241632106\ \(0\)\
\-\ without\\:\\ 0\\.024016886795055294\ \(0\)\
\-\ varying\\:\\ 0\\.023894562874914902\ \(0\)\
\-\ can\\:\\ 0\\.023894217409751325\ \(0\)\
\-\ individuals\\:\\ 0\\.023808730372782774\ \(0\)\
\-\ detection\\:\\ 0\\.023724705005625023\ \(0\)\
\-\ most\\:\\ 0\\.02369669399462837\ \(0\)\
\-\ flat\\:\\ 0\\.02356178207730283\ \(0\)\
\-\ considerations\\:\\ 0\\.02356178207730283\ \(0\)\
\-\ technique\\:\\ 0\\.02348274865266294\ \(0\)\
\-\ it\\:\\ 0\\.023307649234112205\ \(0\)\
\-\ staging\\:\\ 0\\.0232546261351207\ \(0\)\
\-\ men\\:\\ 0\\.023181393667203697\ \(0\)\
\-\ progress\\:\\ 0\\.023181393667203697\ \(0\)\
\-\ reduce\\:\\ 0\\.023181393667203697\ \(0\)\
\-\ sensitivity\\:\\ 0\\.023109480775269194\ \(0\)\
\-\ rectal\\:\\ 0\\.023038840744937804\ \(0\)\
\-\ may\\:\\ 0\\.022913585257271434\ \(0\)\
\-\ too\\:\\ 0\\.022901204432499375\ \(0\)\
\-\ produce\\:\\ 0\\.02283412625650766\ \(0\)\
\-\ health\\:\\ 0\\.022514671205908915\ \(0\)\
\-\ data\\:\\ 0\\.022334592953254732\ \(0\)\
\-\ every\\:\\ 0\\.022051420493653034\ \(0\)\
\-\ requires\\:\\ 0\\.022051420493653034\ \(0\)\
\-\ mucosa\\:\\ 0\\.021943547507390297\ \(0\)\
\-\ treatment\\:\\ 0\\.021689730861408497\ \(0\)\
\-\ determined\\:\\ 0\\.021685970557099452\ \(0\)\
\-\ minimally\\:\\ 0\\.021587420919865225\ \(0\)\
\-\ better\\:\\ 0\\.021491246205356664\ \(0\)\
\-\ once\\:\\ 0\\.021397334636654542\ \(0\)\
\-\ sent\\:\\ 0\\.02130558214700032\ \(0\)\
\-\ healing\\:\\ 0\\.021260484972000802\ \(0\)\
\-\ undergo\\:\\ 0\\.021260484972000802\ \(0\)\
\-\ types\\:\\ 0\\.021171791154757917\ \(0\)\
\-\ anatomic\\:\\ 0\\.021128172605594166\ \(0\)\
\-\ standard\\:\\ 0\\.021128172605594166\ \(0\)\
\-\ combination\\:\\ 0\\.021128172605594166\ \(0\)\
\-\ sigmoid\\:\\ 0\\.02108502561754902\ \(0\)\
\-\ images\\:\\ 0\\.021061992371615327\ \(0\)\
\-\ neoplastic\\:\\ 0\\.021042340103462037\ \(0\)\
\-\ extend\\:\\ 0\\.021000106296412233\ \(0\)\
\-\ develop\\:\\ 0\\.020958314736304287\ \(0\)\
\-\ help\\:\\ 0\\.020916956257149802\ \(0\)\
\-\ arise\\:\\ 0\\.020835503276495995\ \(0\)\
\-\ has\\:\\ 0\\.020798096765547967\ \(0\)\
\-\ earlier\\:\\ 0\\.02079539180798209\ \(0\)\
\-\ discovered\\:\\ 0\\.020755679465177077\ \(0\)\
\-\ majority\\:\\ 0\\.020677420927933607\ \(0\)\
\-\ options\\:\\ 0\\.020525362250014112\ \(0\)\
\-\ women\\:\\ 0\\.02048823586579996\ \(0\)\
\-\ potential\\:\\ 0\\.020343090505948458\ \(0\)\
\-\ invasion\\:\\ 0\\.020307614205489863\ \(0\)\
\-\ leading\\:\\ 0\\.020237593856476804\ \(0\)\
\-\ direct\\:\\ 0\\.020067735987186922\ \(0\)\
\-\ states\\:\\ 0\\.020001766592289357\ \(0\)\
\-\ period\\:\\ 0\\.01990481305886473\ \(0\)\
\-\ despite\\:\\ 0\\.01981015903689608\ \(0\)\
\-\ local\\:\\ 0\\.0195976571166826\ \(0\)\
\-\ american\\:\\ 0\\.019424105533549507\ \(0\)\
\-\ by\\:\\ 0\\.019335905260782472\ \(0\)\
\-\ important\\:\\ 0\\.019285030224332294\ \(0\)\
\-\ department\\:\\ 0\\.019257787405088305\ \(0\)\
\-\ so\\:\\ 0\\.019150638485867236\ \(0\)\
\-\ open\\:\\ 0\\.01882103065054449\ \(0\)\
\-\ growth\\:\\ 0\\.018772653603406363\ \(0\)\
\-\ below\\:\\ 0\\.018748683215899262\ \(0\)\
\-\ using\\:\\ 0\\.018724855936035924\ \(0\)\
\-\ pathologic\\:\\ 0\\.01865421590570453\ \(0\)\
\-\ total\\:\\ 0\\.01865421590570453\ \(0\)\
\-\ test\\:\\ 0\\.0185165795932661\ \(0\)\
\-\ compared\\:\\ 0\\.018405400885437177\ \(0\)\
\-\ best\\:\\ 0\\.018318635348228283\ \(0\)\
\-\ as\\:\\ 0\\.01829217730386559\ \(0\)\
\-\ increase\\:\\ 0\\.0182759498341413\ \(0\)\
\-\ radiology\\:\\ 0\\.018233716027091496\ \(0\)\
\-\ amount\\:\\ 0\\.018212765545792705\ \(0\)\
\-\ tube\\:\\ 0\\.018191924466983544\ \(0\)\
\-\ located\\:\\ 0\\.01800909597359388\ \(0\)\
\-\ full\\:\\ 0\\.017796446974552918\ \(0\)\
\-\ routine\\:\\ 0\\.017630513063422715\ \(0\)\
\-\ partial\\:\\ 0\\.017541223936169123\ \(0\)\
\-\ dysplasia\\:\\ 0\\.01743664876071304\ \(0\)\
\-\ use\\:\\ 0\\.017419482895442675\ \(0\)\
\-\ an\\:\\ 0\\.017411623733925182\ \(0\)\
\-\ third\\:\\ 0\\.017334743883665637\ \(0\)\
\-\ related\\:\\ 0\\.017301345717866186\ \(0\)\
\-\ process\\:\\ 0\\.017075071339983136\ \(0\)\
\-\ second\\:\\ 0\\.01704376876757534\ \(0\)\
\-\ about\\:\\ 0\\.01704376876757534\ \(0\)\
\-\ 60\\:\\ 0\\.01702820906941608\ \(0\)\
\-\ confirmed\\:\\ 0\\.01678716631552465\ \(0\)\
\-\ occur\\:\\ 0\\.016743547766360892\ \(0\)\
\-\ metastasis\\:\\ 0\\.016686121487510357\ \(0\)\
\-\ view\\:\\ 0\\.016671893103375576\ \(0\)\
\-\ diagnosed\\:\\ 0\\.016491397135767565\ \(0\)\
\-\ early\\:\\ 0\\.01641076696874882\ \(0\)\
\-\ mm\\:\\ 0\\.016292796088700334\ \(0\)\
\-\ biopsy\\:\\ 0\\.015958465666715188\ \(0\)\
\-\ was\\:\\ 0\\.015868662451067148\ \(0\)\
\-\ this\\:\\ 0\\.01564592048068339\ \(0\)\
\-\ 12\\:\\ 0\\.015562988174284557\ \(0\)\
\-\ neoplasm\\:\\ 0\\.015541530824089721\ \(0\)\
\-\ 30\\:\\ 0\\.015530845255396762\ \(0\)\
\-\ cause\\:\\ 0\\.015509559564820561\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.015498959140201763\ \(0\)\
\-\ size\\:\\ 0\\.015415154328293861\ \(0\)\
\-\ showed\\:\\ 0\\.015164061632106388\ \(0\)\
\-\ space\\:\\ 0\\.015154339197279565\ \(0\)\
\-\ vascular\\:\\ 0\\.015030056705232178\ \(0\)\
\-\ patient\\:\\ 0\\.014809562837601192\ \(0\)\
\-\ differential\\:\\ 0\\.01479253239883629\ \(0\)\
\-\ known\\:\\ 0\\.014739669936975588\ \(0\)\
\-\ 20\\:\\ 0\\.014687498507498693\ \(0\)\
\-\ image\\:\\ 0\\.014559977834727853\ \(0\)\
\-\ day\\:\\ 0\\.01450183444914235\ \(0\)\
\-\ severe\\:\\ 0\\.014412143988737157\ \(0\)\
\-\ age\\:\\ 0\\.014292999095583361\ \(0\)\
\-\ decreased\\:\\ 0\\.014102002962255273\ \(0\)\
\-\ abdomen\\:\\ 0\\.013891324994908031\ \(0\)\
\-\ when\\:\\ 0\\.013752249685690821\ \(0\)\
\-\ on\\:\\ 0\\.013751713896984978\ \(0\)\
\-\ all\\:\\ 0\\.013552321868383415\ \(0\)\
\-\ time\\:\\ 0\\.013494245633090969\ \(0\)\
\-\ however\\:\\ 0\\.013475073182180587\ \(0\)\
\-\ with\\:\\ 0\\.013373863230514971\ \(0\)\
\-\ been\\:\\ 0\\.01326398828932895\ \(0\)\
\-\ if\\:\\ 0\\.013227869875197872\ \(0\)\
\-\ distal\\:\\ 0\\.013227869875197872\ \(0\)\
\-\ axial\\:\\ 0\\.013150716918239965\ \(0\)\
\-\ due\\:\\ 0\\.013086578747922795\ \(0\)\
\-\ over\\:\\ 0\\.012659143928342071\ \(0\)\
\-\ more\\:\\ 0\\.01250121294253774\ \(0\)\
\-\ symptoms\\:\\ 0\\.012456508657214862\ \(0\)\
\-\ into\\:\\ 0\\.012102249851265446\ \(0\)\
\-\ noted\\:\\ 0\\.012070735414921227\ \(0\)\
\-\ imaging\\:\\ 0\\.01196453693135981\ \(0\)\
\-\ tumor\\:\\ 0\\.011908171249467065\ \(0\)\
\-\ diagnosis\\:\\ 0\\.011801963345024159\ \(0\)\
\-\ small\\:\\ 0\\.011743698696771797\ \(0\)\
\-\ large\\:\\ 0\\.01140711870085026\ \(0\)\
\-\ have\\:\\ 0\\.011373087686794077\ \(0\)\
\-\ up\\:\\ 0\\.011261702108029629\ \(0\)\
\-\ findings\\:\\ 0\\.01123615341295615\ \(0\)\
\-\ after\\:\\ 0\\.011044375322627144\ \(0\)\
\-\ also\\:\\ 0\\.010708682912859847\ \(0\)\
\-\ within\\:\\ 0\\.01048552219378264\ \(0\)\
\-\ which\\:\\ 0\\.010352128723829051\ \(0\)\
\-\ male\\:\\ 0\\.010136496773892334\ \(0\)\
\-\ disease\\:\\ 0\\.009556544519255545\ \(0\)\
\-\ there\\:\\ 0\\.00905869751898438\ \(0\)\
\-\ not\\:\\ 0\\.008987650639827496\ \(0\)\
\-\ no\\:\\ 0\\.007403388622582409\ \(0\)\
